Condition
Ventricular Hypertrophy
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01317329Not ApplicableCompleted
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
NCT00811330Phase 3Unknown
Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis
NCT00689819Not ApplicableCompleted
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
NCT01305304Completed
Magnetic Resonance Technique in the Assessment of Exercise-induced Long- and Short-Term Changes in Cardiac Function and Morphology
Showing all 4 trials